Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression

Background: Nucleos(t)ide analog (NA) treatment for hepatitis B virus (HBV) infection may improve clinically significant portal hypertension (CSPH). Data on hepatic venous pressure gradient (HVPG) and non-invasive tests (NITs) for risk re-stratification in virally suppressed HBV-infected patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jachs, Mathias, Hartl, Lukas, Bauer, David, Simbrunner, Benedikt, Stättermayer, Albert Friedrich, Strassl, Robert, Trauner, Michael, Mandorfer, Mattias, Reiberger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880497/
https://www.ncbi.nlm.nih.gov/pubmed/35207727
http://dx.doi.org/10.3390/jpm12020239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880497/
https://www.ncbi.nlm.nih.gov/pubmed/35207727
http://dx.doi.org/10.3390/jpm12020239

Ejemplares similares